Navigation Links
MedThink Hires Joe Conwell as Executive Creative Director
Date:8/3/2009

RALEIGH, N.C., Aug. 3 /PRNewswire/ -- MedThink Communications, a health care advertising agency with eight doctorate-level scientists who support the creative, digital, advertising, medical communications and public relations services, has hired Joseph R. Conwell as senior vice president, executive creative director.

Conwell's arrival signals a new phase of growth for MedThink, a five-year-old agency that has doubled in size within a two-year period. MedThink's expanding client base has necessitated a heightened emphasis on creative resources and a global perspective on creative strategies to propel the agency to the next level of success.

A seasoned veteran in the advertising industry, Conwell has a wealth of experience managing creative team campaigns for pharmaceutical blockbusters such as Lovenox and Diovan and has executed successful launches for Exforge, Yaz, Kodak Health Imaging and GE Healthcare.

Conwell's national consumer brand work includes Coca-Cola, Procter and Gamble, Lipton Tea and Mars. Among his accomplishments, Conwell helped propel a fledgling agency in Atlanta into a multimillion dollar company, reeling in large corporate accounts such as First Union, Wilkinson Sword, Scripto and Sunbeam.

Conwell's health care advertising clients have included Bristol-Myers Squibb, Merck, Novartis, Ortho-McNeil, Sanofi-Aventis and GE Healthcare, and his therapeutic experience spans across the fields of cardiology, oncology, women's health, virology, nuclear medicine and diagnostic imaging.

Midway through his advertising career, Conwell and a colleague launched and marketed their own brand of premium iced tea, establishing distribution in regional markets and successfully competing with national iced tea brands throughout the South.

The philosophy that fuels his creative success is to engage the best ideas and the best people, buil
'/>"/>

SOURCE MedThink Communications
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MedThink Communications Wins Two Communicator Awards for Its Health Care Web Site Design
2. MedThink Communications Account Director Among First to Receive CMPP Certification in Medical Publications Planning and Development
3. MedThink Hires Associate Scientific Director to Support Its Growing Health Care Clientele
4. MedThink Communications Selected by Salix Pharmaceuticals to Launch New Product
5. MedThink Communications Retained by NanoBio Corporation
6. Wellspring Hires Sanford Devries as Controller
7. National Coalition of Mental Health Consumer/Survivor Organizations Hires Director of Government Relations
8. Cord Blood America Hires Management Team for Its New Stem Cell Laboratory
9. MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP, Group Account Director
10. Pennsylvania Patient Safety Authority Hires Patient Safety Liaison (PSL) to Help Healthcare Facilities Implement Guidance
11. XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... site www.sleeping-with-a-sleeping-disorder.com is asking people ,who ... sleep aids from around the world to donate ... The submissions will be compiled in an ebook ... to be sold from the website in early ... the proceeds ,from sales of the E-book to ...
(Date:12/5/2009)... shown in a phase 1/2 clinical trial that ... of patients newly diagnosed with multiple myeloma, a cancer ... from Dana-Farber Cancer Institute. , Partial responses or better ... with the drug combination in the multi-center study, with ... in the phase 2 population, reports Paul G. Richardson, ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
(Date:12/5/2009)... experts advise , , SATURDAY, Dec. 5 (HealthDay News) -- ... can have bad reactions to certain holiday traditions and ... wheezing, according to the American College of Allergy, Asthma ... live evergreens may choose to decorate with artificial plants, ...
(Date:12/5/2009)... today announced the launch of International Solutions, an innovative new international ... its UK equivalent. In addition to offering customers the flexibility to ... needs and budgets, International Solutions enables customers to tailor their benefits ... , ...
Breaking Medicine News(10 mins):Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AVIVA's Private Health Insurance Products Solutions Go International 2
... 8 Anpath Group, Inc.,(OTC Bulletin Board: ANPG), ... reported several advancements with,the introduction of EquineTru(R). The ... product line with the market launch of,EquineTru(R), an ... at the Atlanta Fall Classic Horse Show., ...
... MBF Healthcare,Acquisition Corp. (AMEX: MBH ), ... that it will host an investor,conference call on ... time to,discuss the recently announced signing of a ... Inc. (along with its,subsidiaries, "CHS"). Hosting the call ...
... (Nasdaq:,STXS), announced today that Bevil J. Hogg, Chief ... will present at the Deutsche Bank,Small- and Mid-Cap ... Naples,Florida on Thursday, February 14, 2008 at 2:40 ... is by invitation only. The audio,presentation will be ...
... of Breast Cancer Movement Gathers Record Attendance for Annual ... ... Susan G. Komen for the Cure(R), the,world,s largest and most ... annual Affiliate Leadership,Conference Feb. 7-9 at the Hilton Anatole in Dallas. ...
... Feb. 7 ORBIS International is,saddened to announce ... the board of,directors, the Honorable Oliver Foot. He ... ), Oliver,s dedication to reduce human ... with ORBIS, a nonprofit global development,organization that transcends ...
... in Past Three Years and Fourth Consecutive Quarterly ... Revenue Increase Over Prior Year, ... of BioZ(R) Impedance Cardiography (ICG),technology, today reported financial results for its ... and do not include,results for Vermed which was sold on August ...
Other Medicine News:Health News:Anpath Group, Inc. Announces Advancements with Animal Care Line 2Health News:Anpath Group, Inc. Announces Advancements with Animal Care Line 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4Health News:Susan G. Komen for the Cure(R) Hosts Annual Affiliate Leadership Conference in Dallas 2Health News:Susan G. Komen for the Cure(R) Hosts Annual Affiliate Leadership Conference in Dallas 3Health News:ORBIS International Announces the Death of the Honorable Oliver Foot, President and Board Member 2Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 2Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 3Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 4Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 5Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 6Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 7
(Date:12/4/2009)... 4 Bayer Diabetes Care today announced the three grand ... Nick Jonas, of the Jonas Brothers, selected the winning video ... The grand prize is an in-person meeting today with Nick. ... like Nick, are: Caleb, age 6, from Danbury, CT, who ...
(Date:12/4/2009)... Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin ... Trademark Office has allowed its patent application on a ... manufacture of the Company,s DCVax® therapeutic cancer vaccines. ... high concentration of dendritic cells (which are the critical ...
(Date:12/4/2009)... anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder ... the comorbidities reported to occur more often in ... epilepsy versus those without an epilepsy diagnosis, according ... the U.S. ,, Findings from " CNS-Related Comorbidities ...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3TV Spotlight on DataDeed and Living Will Solutions 57725 1TV Spotlight on DataDeed and Living Will Solutions 57725 2Radiological treatment method spares patients surgery and offers 89 percent cost savings 57721 1Surgeon Battling Own Cancer Developed New Treatment 57718 1Surgeon Battling Own Cancer Developed New Treatment 57718 2Surgeon Battling Own Cancer Developed New Treatment 57718 3
... from CHARM Study in Remission at One Year ... Maintained Remission at Two ... an,open-label extension study of two Abbott pivotal studies, CHARM and ... long-term clinical remission and clinical,response, respectively, according to data presentations ...
... Alba Therapeutics Corporation,announced today that data from ... Clinical Advances in Celiac Disease session at the ... Results of the randomized,double- blind, placebo controlled study ... reactivation by gluten challenge in celiac,subjects in remission(1) ...
Other Medicine Technology:Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 2Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 3Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 4Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 5Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 6Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 7Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 2Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 3Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 4Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 5
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
Medicine Products: